Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful

We present a commentary on the inclusion criteria and outcome measures of the major randomized trials on multiple sclerosis. A qualitative comparison of the characteristics of the enrolled patients is done. The objective is to stimulate a discussion about the need to improve research strategies. The discovery of new drugs studied without personalized criteria does not allow for useful advances in knowledge.
Source: Neurology and Therapy - Category: Neurology Source Type: research